ישראל - עברית - Ministry of Health

teva medical marketing ltd. - citric acid anhydrous; glucose as monohydrate; sodium citrate - תמיסה - citric acid anhydrous 730 mg / 100 ml; sodium citrate 2.2 g / 100 ml; glucose as monohydrate 2.45 g / 100 ml - glucose - glucose - for use with cytapheresis device only.

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soybean oil 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1.0 g / 1000 ml; l-serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5 g / 1000 ml; l-histidine 3 g / 1000 ml; aminoacetic acid 11 g / 1000 ml; l-arginine 12 g / 1000 ml; l- alanine 14 g / 1000 ml; fish oil 30 g / 1000 ml - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-serine; olive oil; soya oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - fish oil 30 g; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soya oil 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1.0 g / 1000 ml; l-serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - soybean oil 60 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- valine 6.2 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; fish oil 30 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l-serine 6.5 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; taurine 1.0 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soybean oil 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1.0 g / 1000 ml; l-serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - acetylsalicylic acid - acetylsalicylic acid 100 mg - acetylsalicylic acid

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 500 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 750 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 1000 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - risedronic acid as sodium hemipentahydrate - טבליה - risedronic acid as sodium hemipentahydrate 150 mg - risedronic acid